How to Qualify a Silodosin API Supplier in India

Qualifying a Silodosin API supplier comes down to five things: certification you can read the scope of, a specification you can hold a batch against, analytical documentation, dependable supply, and a track record. We have manufactured APIs in Hyderabad since 1943 and make Silodosin under an ISO 9001:2015 quality system covering API development, manufacture and sale. What that certificate and our WHO-GMP certificate do and do not cover for Silodosin is stated below.

Understanding Silodosin and Its Therapeutic Significance

Silodosin is an α1-adrenoceptor antagonist with the highest selectivity for the α1A subtype. Blocking that receptor relaxes prostatic and urethral smooth muscle, easing the voiding symptoms of benign prostatic hyperplasia. It is an oral molecule, formulated as capsules.

Silodosin API is a white to off-white crystalline powder. Molecular formula C25H32F3N3O4, molecular weight 495.53 g/mol. Very soluble in acetic acid, freely soluble in ethanol, insoluble in water, a profile that shapes the crystallisation step and the dissolution work downstream. CAS 160970-54-7.

Write our published limits into your purchase order: total impurities NMT 1.0%, any unspecified impurity NMT 0.1%, loss on drying NMT 1.0% w/w, residue on ignition NMT 0.1% w/w. Our breakdown of Silodosin API powder quality standards explains the reasoning behind each figure.

Why India Is Preferred for API Procurement

The reasons are structural: deep synthesis chemistry capability, established multi-step manufacturing, and a regulatory framework built on the Drugs and Cosmetics Act, 1940 with CDSCO oversight of export documentation. That makes India a shortlist worth having, not a guarantee. Standards vary between sites, and the only way to know what a supplier holds is to read the certificates.

Critical Parameters When Choosing a Silodosin API Supplier

1. Regulatory compliance, and its exact scope. A WHO-GMP certificate issued under the export scheme names the products in its joint inspection report. An ISO 9001:2015 certificate covers a management system, not a molecule. An EU Written Confirmation is issued per product, never per company. Our note on GMP certification for Silodosin API manufacturers sets out what each document proves.

2. Manufacturing capability. Match capacity to your forecast, not to the largest number on the brochure. ICH Q7 requires validated cleaning between campaigns; ask to see the protocol, and ask whether there is a pilot facility for scale-up.

3. Analytical documentation. A Certificate of Analysis against the monograph you are buying to, method validation, stability data, and an impurity profile covering organic, inorganic and residual solvents per ICH Q3A and Q3C.

4. Supply chain reliability. Delivery history, packaging that survives your shipping lane, a second source for the critical intermediate. Ask what happens to your order when a raw material vendor fails an audit.

5. Track record. Years in operation, breadth of portfolio, audit history. A supplier inspected repeatedly by customers and regulators has been forced to keep its records straight.

Bio-Synth’s Credentials, Document by Document

We are Biochemical and Synthetic Products Private Limited, and we have manufactured APIs from our Balanagar site in Hyderabad since 1943. Silodosin sits in a portfolio spanning anti-TB, cardiology, psychiatry, urology, antihistamine and anti-diabetic molecules. The systems behind it are set out on our quality page.

One point most supplier pages get wrong: a WHO-GMP certificate under the export scheme covers the site and lists specific products. Ours names the two PAS Sodium grades. It is evidence the facility has been jointly inspected and found GMP-conformant. It is not a product certification for Silodosin, and no supplier’s should be read that way.

Product data, the published specification and the quotation process are on our page for Silodosin API manufacturers in India.

Inside the Manufacturing Flow: PAS Sodium as a Worked Example

PAS Sodium is a useful example because it is one of the two products named on our WHO-GMP certificate, so the process behind it has been inspected end to end.

Raw material sourcing. Qualified vendors; identity and purity testing on receipt before release to production.

Synthesis. Controlled reaction under written procedures, with in-process checks at defined stages.

Crystallisation and separation. Where impurity rejection and polymorphic form are decided.

Drying and milling. Loss on drying inside the monograph limit, particle size distribution controlled. That step matters more than buyers expect; Silodosin API in formulations covers its effect on blend uniformity and dissolution.

Quality control. The identity, assay, related-substances and residual-solvent tests the monograph calls for, run before release.

Packing and dispatch. GMP documentation, pack size to requirement, CoA and batch traceability with every consignment.

Regulatory and Documentation Support

Documentation is not paperwork you chase after the purchase order. It is the purchase order. We issue a Certificate of Analysis for every batch against the agreed specification; for Silodosin it typically covers appearance, solubility, IR identification, assay, related substances and residual solvents.

Open and closed part DMF, real-time and accelerated stability data, elemental impurity data, TSE/BSE non-animal-origin statement is available upon request and subject to MOQ requirements.

Trends in Global API Sourcing

Procurement has moved from price to data integrity: buyers now ask for the audit trail behind the CoA, not just the CoA.

Generic competition compresses cost of goods. Once a urology molecule is open to multiple entrants, a low-variation API supply is what keeps a formulation profitable. Where the cost differences come from is set out in our look at why Silodosin API prices vary across Indian suppliers.

Vendor lists are also consolidating. Auditing twelve suppliers costs more than auditing four, so teams favour multi-therapeutic manufacturers.

Therapeutic Segment and Bio-Synth API Portfolio

Buying several molecules from one qualified site cuts audit load. The full API portfolio lists every product with its specification.

Partner with Bio-Synth

Choosing a Silodosin API manufacturer is a documentation exercise before it is a commercial one. Read the certificates. Check their scope. Hold the specification against a real batch. Then talk price.

Send your volume, pharmacopoeial grade and target market through our contact page, and our team will come back with the specification, a sample CoA and the certificate scopes for review.

Frequently Asked Questions

What is Silodosin API used for?

It treats the signs and symptoms of benign prostatic hyperplasia, the non-malignant enlargement of the prostate gland that causes lower urinary tract symptoms in older men. Its formulation role is covered in what Silodosin API is used for.

What specification does Bio-Synth publish for Silodosin API?

Total impurities NMT 1.0%, any unspecified impurity NMT 0.1%, loss on drying NMT 1.0% w/w, residue on ignition NMT 0.1% w/w. White to off-white crystalline powder, C25H32F3N3O4, 495.53 g/mol.

What certifications does Bio-Synth hold?

ISO 9001:2015 from DNV Business Assurance UK Limited (UKAS accredited), covering development, manufacture and sale of APIs, drug intermediates, biological products and liver injectable; and a WHO-GMP certificate from the Telangana Drugs Control Administration valid to 5 June 2027. Manufacturing follows ICH Q7 principles.

How do I request a quotation?

Send the molecule, pharmacopoeial grade, annual volume and target delivery window, along with the market you intend to file in; that determines which documents you will need.